2024-09-17 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
AGEN
Agenus Inc.
|
Buy |
10.73% |
11.15% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.35% |
7.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
11.95% |
14.42% |
2024-08-29 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.83% |
-3.83% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
8.86% |
-0.5% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.72% |
3.45% |
2024-09-09 |
The percentage of cash held in the portfolio is:
40.57%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
APLS |
Sell
All
|
-8.89% |
TVTX |
Sell
All
|
48.65% |
Assets Rebalanced
None
2024-09-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.85% |
-1.69% |
2024-08-22 |
AGEN
Agenus Inc.
|
Buy |
10% |
-0.18% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.17% |
1.71% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
12% |
10.8% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
12.74% |
33.75% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.01% |
-5.46% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
8.65% |
-6.37% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.77% |
0.26% |
2024-09-09 |
The percentage of cash held in the portfolio is:
18.81%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
CARA |
Sell
All
|
-18.08% |
Assets Rebalanced
None
2024-09-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.04% |
0.21% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.06% |
-9.62% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.4% |
-6.22% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.34% |
3.43% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
11.62% |
7.2% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
12.77% |
33.96% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.85% |
-7.1% |
2024-09-04 |
NVCR
NovoCure Limited
|
Buy |
8.5% |
-7.98% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.81% |
0.63% |
2024-09-09 |
The percentage of cash held in the portfolio is:
10.61%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALDX |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-09-09 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10.48% |
3% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.56% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.21% |
-9.51% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.62% |
4.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
11.56% |
5.05% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
11.07% |
14.37% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
8.73% |
-9.84% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.1% |
-3.01% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
8.78% |
-6.48% |
2024-09-06 |
MYGN
Myriad Genetics, Inc.
|
Buy |
8.89% |
0% |
2024-09-09 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ORGO |
Sell
All
|
-12.72% |
Assets Rebalanced
None
2024-09-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
10% |
-1.42% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.46% |
-6.71% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.5% |
-6.41% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.27% |
-8.59% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.41% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
11.6% |
5.72% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.98% |
3.44% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.07% |
-6.01% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.35% |
0% |
2024-09-05 |
NVCR
NovoCure Limited
|
Buy |
9.35% |
0% |
2024-09-06 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.61% |
-5.21% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.67% |
-4.59% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.52% |
-6.12% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
8.99% |
-11.33% |
2024-08-23 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.41% |
2.86% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
11.4% |
3.96% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
10.1% |
4.69% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.59% |
-0.55% |
2024-09-04 |
ALDX
Aldeyra Therapeutics, Inc.
|
Buy |
9.35% |
0% |
2024-09-05 |
The percentage of cash held in the portfolio is:
11.35%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CERS |
Sell
All
|
-11.34% |
EGRX |
Sell
All
|
-11.35% |
Assets Rebalanced
None
2024-09-04 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.85% |
-2.65% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.76% |
-3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.77% |
-3.5% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.16% |
-9.51% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.29% |
-7.98% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
10.04% |
-0.57% |
2024-08-27 |
PODD
Insulet Corporation
|
Buy |
11.07% |
1.11% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
9.81% |
-10.38% |
2024-08-29 |
TVTX
Travere Therapeutics, Inc.
|
Buy |
9.62% |
0% |
2024-09-04 |
ESPR
Esperion Therapeutics, Inc.
|
Buy |
9.62% |
0% |
2024-09-04 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ARDX |
Sell
All
|
-11.62% |
NEOG |
Sell
All
|
-6.34% |
Assets Rebalanced
None
2024-08-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.42% |
-3.45% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.34% |
-4.2% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.1% |
3.53% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.13% |
3.79% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.11% |
-6.58% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.16% |
-5.88% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.35% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
10.3% |
-2.15% |
2024-08-28 |
PODD
Insulet Corporation
|
Buy |
10.55% |
0% |
2024-08-29 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
10.55% |
0% |
2024-08-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ARDX
Ardelyx, Inc.
|
Buy |
9.33% |
-2.35% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.49% |
-0.64% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.93% |
3.89% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.01% |
4.66% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.84% |
2.93% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.3% |
-2.52% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.16% |
-4% |
2024-08-27 |
NEOG
Neogen Corporation
|
Buy |
10.32% |
0% |
2024-08-28 |
The percentage of cash held in the portfolio is:
22.63%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
4.72% |
Assets Rebalanced
None
2024-08-27 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
11.75% |
6.09% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
9.28% |
-0.94% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.36% |
-0.05% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
10.03% |
7.07% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
10.11% |
7.87% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
10.06% |
7.31% |
2024-08-23 |
CERS
Cerus Corporation
|
Buy |
9.35% |
0% |
2024-08-27 |
AADI
Aadi Bioscience, Inc.
|
Buy |
9.35% |
0% |
2024-08-27 |
The percentage of cash held in the portfolio is:
20.7%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
11.05% |
-4.32% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
9.27% |
-5.02% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.59% |
-1.79% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.49% |
-2.83% |
2024-08-22 |
CARA
Cara Therapeutics, Inc.
|
Buy |
9.77% |
0% |
2024-08-23 |
AGEN
Agenus Inc.
|
Buy |
9.77% |
0% |
2024-08-23 |
The percentage of cash held in the portfolio is:
41.07%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
11.08% |
-2.95% |
2024-07-29 |
ARDX
Ardelyx, Inc.
|
Buy |
9.66% |
0% |
2024-08-22 |
APLS
Apellis Pharmaceuticals, Inc.
|
Buy |
9.66% |
0% |
2024-08-22 |
ORGO
Organogenesis Holdings Inc.
|
Buy |
9.66% |
0% |
2024-08-22 |
The percentage of cash held in the portfolio is:
59.94%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
11.22% |
-1.57% |
2024-07-29 |
The percentage of cash held in the portfolio is:
88.78%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RCM |
Sell
All
|
7.37% |
Assets Rebalanced
None
2024-08-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
RCM
R1 RCM Inc.
|
Buy |
9.31% |
7.37% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
10.88% |
-4.91% |
2024-07-29 |
The percentage of cash held in the portfolio is:
79.81%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
OPK |
Sell
All
|
13.64% |
Assets Rebalanced
None
2024-08-08 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
8.58% |
-3.03% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
9.46% |
7.14% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
10.76% |
-7.66% |
2024-07-29 |
The percentage of cash held in the portfolio is:
71.2%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RMD |
Sell
All
|
1.39% |
Assets Rebalanced
None
2024-08-06 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
OPK
OPKO Health, Inc.
|
Buy |
8.72% |
-0.76% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
9.38% |
7.06% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
10.96% |
-5.3% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
10.77% |
3.67% |
2024-07-31 |
The percentage of cash held in the portfolio is:
60.17%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
PDSB |
Sell
All
|
-10.51% |
Assets Rebalanced
None
2024-08-05 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
7.94% |
-8.52% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
8.87% |
2.27% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
9.33% |
7.83% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
11.2% |
-1.96% |
2024-07-29 |
RMD
ResMed Inc.
|
Buy |
11.02% |
7.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
51.64%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
HQY |
Sell
All
|
-11.82% |
HCSG |
Sell
All
|
-6.49% |
Assets Rebalanced
None
2024-08-02 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
7.88% |
-8.24% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
8.98% |
4.55% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
9.28% |
8.44% |
2024-07-18 |
CYH
Community Health Systems, Inc.
|
Buy |
11.13% |
-1.57% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
10.87% |
-3.84% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.19% |
-3.72% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
10.47% |
3.13% |
2024-07-31 |
The percentage of cash held in the portfolio is:
32.21%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
FATE |
Sell
All
|
-12.39% |
Assets Rebalanced
None
2024-08-01 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
PDSB
PDS Biotechnology Corporation
|
Buy |
8.53% |
1.14% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.08% |
7.58% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
8.32% |
-1.15% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.16% |
-4.31% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
11.48% |
3.34% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
10.77% |
-3.09% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.27% |
-1.12% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
10.22% |
2.5% |
2024-07-31 |
The percentage of cash held in the portfolio is:
24.18%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
VRDN |
Sell
All
|
27.55% |
Assets Rebalanced
None
2024-07-31 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
12.24% |
26.42% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
8.38% |
-1.7% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.23% |
8.33% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
8.41% |
-1% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
7.93% |
-7.9% |
2024-07-24 |
CYH
Community Health Systems, Inc.
|
Buy |
11.37% |
1.38% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
10.86% |
-3.16% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.43% |
-0.43% |
2024-07-30 |
RMD
ResMed Inc.
|
Buy |
10.07% |
0% |
2024-07-31 |
The percentage of cash held in the portfolio is:
12.07%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
SMTI |
Sell
All
|
-8.69% |
CLDX |
Sell
All
|
-12.36% |
Assets Rebalanced
None
2024-07-30 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
12.28% |
30.89% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
8.97% |
8.52% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
8.95% |
8.33% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
8.02% |
-2.61% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.11% |
-2.87% |
2024-07-24 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.42% |
-4.26% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
10.29% |
-5.45% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
11.07% |
1.77% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
10.7% |
-1.69% |
2024-07-29 |
HCSG
Healthcare Services Group, Inc.
|
Buy |
9.18% |
0% |
2024-07-30 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
PTGX |
Sell
All
|
-7.35% |
Assets Rebalanced
None
2024-07-29 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
11.63% |
26.12% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
8.95% |
10.23% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.1% |
12.12% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
8.08% |
-0.19% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.01% |
-2.33% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.32% |
-3.84% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.86% |
1.6% |
2024-07-26 |
SMTI
Sanara MedTech Inc.
|
Buy |
10.69% |
0% |
2024-07-29 |
CYH
Community Health Systems, Inc.
|
Buy |
10.69% |
0% |
2024-07-29 |
HQY
HealthEquity, Inc.
|
Buy |
10.69% |
0% |
2024-07-29 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-26 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
11.45% |
23.69% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.12% |
11.93% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
8.77% |
7.58% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
8.06% |
-0.84% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
7.99% |
-3.05% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.66% |
-0.76% |
2024-07-25 |
CLDX
Celldex Therapeutics, Inc.
|
Buy |
10.74% |
0% |
2024-07-26 |
The percentage of cash held in the portfolio is:
34.21%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
CYH |
Sell
All
|
48.75% |
Assets Rebalanced
None
2024-07-25 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
CYH
Community Health Systems, Inc.
|
Buy |
12.8% |
35.31% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
11.33% |
19.76% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
8.91% |
6.96% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
8.96% |
7.58% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
8.38% |
0.92% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
7.83% |
-7% |
2024-07-24 |
PTGX
Protagonist Therapeutics, Inc.
|
Buy |
9.95% |
0% |
2024-07-25 |
The percentage of cash held in the portfolio is:
31.85%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
ACAD |
Sell
All
|
16.37% |
EGRX |
Sell
All
|
20.09% |
Assets Rebalanced
None
2024-07-24 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
10.92% |
14.55% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
12.28% |
28.79% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
11.77% |
26.56% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
10.99% |
18.17% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.84% |
20.17% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
8.94% |
9.09% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
8.42% |
3.07% |
2024-07-18 |
FATE
Fate Therapeutics, Inc.
|
Buy |
8.28% |
0% |
2024-07-24 |
The percentage of cash held in the portfolio is:
18.56%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-22 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
10.91% |
11.78% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
12.79% |
31.03% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
11.21% |
17.81% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
10.43% |
9.54% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.22% |
9.94% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.46% |
12.88% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
8.52% |
2% |
2024-07-18 |
The percentage of cash held in the portfolio is:
27.46%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
ALT |
Sell
All
|
-16.04% |
Assets Rebalanced
None
2024-07-19 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
11.05% |
13.35% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
12.54% |
28.57% |
2024-06-25 |
CYH
Community Health Systems, Inc.
|
Buy |
11.2% |
17.81% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
10.42% |
9.54% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.18% |
9.66% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
7.33% |
-12.43% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
9.64% |
15.15% |
2024-07-11 |
RCM
R1 RCM Inc.
|
Buy |
8.23% |
-1.46% |
2024-07-18 |
The percentage of cash held in the portfolio is:
20.4%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
RARE |
Sell
All
|
7.35% |
WST |
Sell
All
|
-5.09% |
Assets Rebalanced
None
2024-07-18 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
10.92% |
15.55% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
12.61% |
33.48% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
10.41% |
10.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
11.35% |
23.12% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
10.63% |
15.37% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.25% |
13.92% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
8.13% |
0.13% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
8.73% |
7.58% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
7.89% |
-1.88% |
2024-07-12 |
RCM
R1 RCM Inc.
|
Buy |
8.09% |
0% |
2024-07-18 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
Asset |
Action |
Perf % |
BHVN |
Sell
All
|
0.3% |
Assets Rebalanced
None
2024-07-12 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
10.77% |
11.15% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
13.04% |
34.6% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
10.67% |
10.14% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
10.95% |
15.94% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.26% |
-1.97% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
9.17% |
10.23% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
8.73% |
4.89% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
8.54% |
2.67% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
8.63% |
3.79% |
2024-07-11 |
WST
West Pharmaceutical Services, Inc.
|
Buy |
8.24% |
0% |
2024-07-12 |
The percentage of cash held in the portfolio is:
2%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-11 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
10.87% |
7.75% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
13.61% |
34.82% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
10.76% |
6.55% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
10.27% |
4.37% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.14% |
-7.12% |
2024-07-02 |
PDSB
PDS Biotechnology Corporation
|
Buy |
8.67% |
0% |
2024-07-11 |
BHVN
Biohaven Ltd.
|
Buy |
8.67% |
0% |
2024-07-11 |
ALT
Altimmune, Inc.
|
Buy |
8.67% |
0% |
2024-07-11 |
OPK
OPKO Health, Inc.
|
Buy |
8.67% |
0% |
2024-07-11 |
The percentage of cash held in the portfolio is:
10.67%
New Assets Added
Assets Removed
None
Assets Rebalanced
None
2024-07-10 00:00:00
: Portfolio change date
Asset |
Action |
Weight |
PnL |
Entry Date |
ACAD
ACADIA Pharmaceuticals Inc.
|
Buy |
10.89% |
7.87% |
2024-06-25 |
EGRX
Eagle Pharmaceuticals, Inc.
|
Buy |
13.67% |
35.49% |
2024-06-25 |
RARE
Ultragenyx Pharmaceutical Inc.
|
Buy |
10.7% |
6.02% |
2024-06-26 |
CYH
Community Health Systems, Inc.
|
Buy |
10.21% |
3.75% |
2024-06-28 |
VRDN
Viridian Therapeutics, Inc.
|
Buy |
9.2% |
-6.59% |
2024-07-02 |
The percentage of cash held in the portfolio is:
45.34%
New Assets Added
None
Assets Removed
Asset |
Action |
Perf % |
NVRO |
Sell
All
|
-11.61% |
Assets Rebalanced
None